Lv4
440 积分 2024-10-08 加入
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective
19天前
已完结
Population Pharmacokinetic and Pharmacodynamic Modeling and Effects on Platelet Counts of Different Dosages of Eltrombopag in Chinese Patients With Chronic Primary Immune Thrombocytopenia
19天前
已完结
Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
28天前
已完结
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer
1个月前
已完结
Ordinal regression models made easy: A tutorial on parameter interpretation, data simulation and power analysis
1个月前
已完结
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib
1个月前
已完结
Population Pharmacokinetics of Total and Free Erdafitinib in Adult Healthy Volunteers and Cancer Patients: Analysis of Phase 1 and Phase 2 Studies
1个月前
已完结
A translational model-based approach to inform the choice of the dose in phase 1 oncology trials: the case study of erdafitinib
1个月前
已完结
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
2个月前
已完结
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
2个月前
已完结
皖公网安备34019202002308
